Leo Wealth LLC raised its position in shares of The Clorox Company (NYSE:CLX – Free Report) by 33.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,514 shares of the company’s stock after buying an additional 871 shares during the quarter. Leo Wealth LLC’s holdings in Clorox were worth $571,000 as of its most recent SEC filing.
Other large investors have also added to or reduced their stakes in the company. Brooklyn Investment Group increased its position in Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after purchasing an additional 95 shares during the last quarter. Prospera Private Wealth LLC purchased a new position in shares of Clorox in the 3rd quarter worth $27,000. Continuum Advisory LLC increased its holdings in shares of Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after buying an additional 138 shares during the last quarter. Carolina Wealth Advisors LLC purchased a new stake in shares of Clorox during the 3rd quarter valued at about $48,000. Finally, Friedenthal Financial bought a new position in shares of Clorox in the 3rd quarter valued at about $49,000. Institutional investors own 78.53% of the company’s stock.
Clorox Stock Up 0.6 %
Shares of NYSE:CLX opened at $148.51 on Friday. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The stock has a market cap of $18.38 billion, a P/E ratio of 51.75, a price-to-earnings-growth ratio of 2.92 and a beta of 0.42. The business’s 50 day moving average is $161.44 and its 200 day moving average is $158.59. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08.
Clorox Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 3.29%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s payout ratio is 170.04%.
Wall Street Analyst Weigh In
A number of brokerages have issued reports on CLX. Barclays upped their price objective on Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research report on Wednesday. Wells Fargo & Company increased their price target on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a report on Tuesday. Royal Bank of Canada reiterated a “sector perform” rating and set a $150.00 price objective on shares of Clorox in a research report on Thursday, January 30th. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and increased their target price for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. Finally, JPMorgan Chase & Co. upped their price target on shares of Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a report on Tuesday. Four equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $158.21.
Get Our Latest Research Report on Clorox
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading
- Five stocks we like better than Clorox
- What is Put Option Volume?
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- Business Services Stocks Investing
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- What is the MACD Indicator and How to Use it in Your Trading
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.